Papers: 10.1002/cam4.2492

https://doi.org/10.1002/cam4.2492

Risk stratification for lung adenocarcinoma on EGFR and TP53 mutation status, chemotherapy, and PD‐L1 immunotherapy

Cited by: 8
Author(s): Chih‐Hsun Wu, Ming‐Jing Hwang
Published: about 7 years ago

Software Mentions 1